Cargando…
Possible strategies to cross the blood–brain barrier
The mucopolysaccharidoses (MPS) are a heterogeneous group of in-born metabolic conditions caused by genetic defects that result in the absence or severe deficiency of one of the lysosomal hydrolases responsible for the degradation of glycosaminoglycans (GAGs). Such enzyme deficiency causes accumulat...
Autores principales: | Bellettato, Cinzia M., Scarpa, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238258/ https://www.ncbi.nlm.nih.gov/pubmed/30442184 http://dx.doi.org/10.1186/s13052-018-0563-0 |
Ejemplares similares
-
Research activity and capability in the European reference network MetabERN
por: Heard, Jean-Michel, et al.
Publicado: (2019) -
One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN
por: Paneghetti, Laura, et al.
Publicado: (2022) -
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network
por: Heard, Jean-Michel, et al.
Publicado: (2020) -
Social and medical needs of rare metabolic patients: results from a MetabERN survey
por: Sestini, Sylvia, et al.
Publicado: (2021) -
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
por: Cheng, Guowang, et al.
Publicado: (2022)